| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |